Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides.

Autor:in

Aichberger, KJ; Mayerhofer, M; Krauth, MT; Skvara, H; Florian, S; Sonneck, K; Akgul, C; Derdak, S; Pickl, WF; Wacheck, V; Selzer, E; Monia, BP; Moriggl, R; Valent, P; Sillaber, C

Schlagwörter

CHRONIC MYELOGENOUS LEUKEMIA; ABL TYROSINE KINASE; COLONY-STIMULATING FACTOR; BCR-ABL; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR-MECHANISMS; TRANSCRIPTION FACTOR; CLINICAL RESISTANCE; HEMATOPOIETIC-CELLS; SIGNALING PATHWAY

ISSN/eISSN

0006-4971 -

WoS ID

WOS:000228344500050